テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
28 nov. 2018 18h17 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリア メルボルン、CEO：Dr. Christian...
Advanced Proteome Therapeutics Reports Progress on Collaboration with Noria Pharmaceuticals
15 oct. 2018 08h30 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), is pleased to announce the successful...
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
08 oct. 2018 02h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Global Markets for Research Antibodies to Reach $3.0B by 2022
16 janv. 2018 06h30 HE
|
BCC Research
WELLESLEY, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Dramatic change in leading antibody manufacturing technologies is spurring growth in research antibodies, which have the potential to comprise a...
ContraFect Corporation Announces Issuance of Patent for Novel Approach to Treat Influenza Using Inhaled Antibodies
03 août 2017 16h01 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - August 03, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...
"Speak What You Think, So I Can Learn"
16 avr. 2015 14h11 HE
|
ARUP Laboratories
SALT LAKE CITY, April 16, 2015 (GLOBE NEWSWIRE) -- The go-to-book for body fluids, Kjeldsberg's Body Fluid Analysis (4th edition)was recently updated and released by the American Society for Clinical...
Avid Bioservices to Highlight Novel Methods for Increasing Protein Expression and Developing an Optimized Upstream Process at IBC's Biopharmaceutical Development & Production Week Conference
24 mars 2014 15h23 HE
|
Avid Bioservices
TUSTIN, CA--(Marketwired - Mar 24, 2014) - Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc., today announced that recent studies evaluating a new suspension...
Avid Bioservices to Present Two Successful Case Studies Highlighting Development and Manufacturing Expertise That Supports Commercial Production at Upcoming Industry Events
11 sept. 2013 19h55 HE
|
Avid Bioservices
TUSTIN, CA--(Marketwired - Sep 11, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., today announced presentations at the following upcoming industry events:
...
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina
04 mars 2013 08h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 4, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that ANMAT (Administracion Nacional de Medicamentos, Alimentos y...
Avid Bioservices Announces Completion of Facility Upgrades in Response to Increased Demand for Its Contract Manufacturing Services
13 déc. 2012 11h00 HE
|
Avid Bioservices
TUSTIN, CA--(Marketwire - Dec 13, 2012) - Avid Bioservices, Inc, a contract manufacturing organization (CMO) focused on the process development and manufacturing of monoclonal antibodies, proteins...